U8G-25115-93155 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-13
Dose 1 — Janssen/Johnson & Johnson
2021-03-15
Registered in v-safe
2021-03-15
Survey response — days 1–6 daily, dose 1
MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Lack of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-16
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea exertional — Feeling: Poor · Site: Pain · Fever · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Struggle breathing with exercise

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Swelling · None · Be unable to do your normal daily activities

Adult check-in
2021-03-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-20
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-27
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-03
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-04-10
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-04-18
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-04-24
Survey response — day 42, single dose
MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Cough, cold, sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-12
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-09-12
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-01-07
Dose 2 — Pfizer-BioNTech
2022-01-07
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2022-01-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-01-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2022-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-01-14
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2022-01-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2022-01-28
Survey response — day 21, dose 2
MedDRA: Cough, Fatigue, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough, sore throat, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-02-04
Survey response — day 28, dose 2
MedDRA: Cough, Fatigue, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sore throat, tired, cough

MedDRA releases: 2024-11 · check-in free text available
2022-02-11
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2022-02-18
Survey response — day 42, dose 2
MedDRA: Diarrhoea, Fatigue, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Vomiting, diherrea, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-04-08
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-07-08
Survey response — 6 months, dose 2
MedDRA: Cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Cough

MedDRA releases: 2024-11 · check-in free text available
2023-01-10
Survey response — 12 months, dose 2
MedDRA: Oropharyngeal pain, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Janssen/Johnson & Johnson
2	2022-01-07	Pfizer-BioNTech	No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-15

Systemic reaction (other): Lack of appetite

2021-03-16

Systemic reaction (other): Struggle breathing with exercise

Release 7 — day 42, single dose

2021-04-24

Symptoms: Cough, cold, sore throat

Release 11 — day 21, dose 2

2022-01-28

Symptoms: Cough, sore throat, fatigue

Release 11 — day 28, dose 2

2022-02-04

Symptoms: Sore throat, tired, cough

Release 11 — day 42, dose 2

2022-02-18

Symptoms: Vomiting, diherrea, fatigue

Release 12 — 6 months, dose 2

2022-07-08

Symptoms: Cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Diarrhoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Nasopharyngitis	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Vomiting	·	·	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Dyspnoea exertional	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release